Project Grant HT94252310928
Award Date
9/30/23
Completion Date
9/29/26
Dollars Obligated
$2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
Trustees of Indiana University was awarded a $724,697 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to optimize muscle function in composite tissue injuries with segmental bone defects. The three-year award beginning May 1, 2023 will support Indiana University's research efforts to investigate medical solutions for battlefield injuries involving both soft tissue damage and bone loss. Through this funding,...
This $938,053 federal project grant awarded by the Defense Health Agency on September 30, 2023 under the Military Medical Research and Development program (CFDA 12.420) supports research on the prevalence of neuropathic pain pathophysiology associated with ankle fracture. The awardee, Trustees of Indiana University, will conduct this 4-year research project to advance scientific understanding and develop new treatment approaches for this condition affecting military service members and veterans....
This $487,623 federal Project Grant, awarded on September 30, 2023 by the Defense Health Agency (DHA) under the Military Medical Research and Development CFDA program (12.420), supports research on the prevalence of neuropathic pain pathophysiology associated with ankle fracture. The award recipient is the Trustees of Indiana University, doing business as Indiana University, a major public research university with extensive expertise in biomedical sciences research. The project aims to advance...
The Defense Health Agency awarded Trustees of Indiana University, doing business as Indiana University, a $704,674 Project Grant under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop a preclinical model for gene therapy of Fanconi anemia group C. Through this award with a completion date of September 29, 2026, Indiana University will perform research to investigate medical solutions for battlefield conditions by developing a preclinical model for a...
The Trustees of Indiana University were awarded a $1.3 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2023 to June 30, 2026 to prevent post-traumatic epilepsy by inhibiting the initiation of innate immune reaction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care...
The Trustees of Indiana University were awarded a $3,930,678 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2022 to June 30, 2024 to target replication stress in pediatric and young adult osteosarcoma. The Military Medical Research and Development program supports biomedical research to transform military and public health care through innovative solutions. This award...
This $1,592,860 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research to develop ultrasensitive proteomics technologies for predicting and assessing the efficacy of treatments for Type 1 diabetes. The research, to be conducted at the University of Virginia from January 1, 2025 to December 31, 2028, aims to transform healthcare for military service members and the public through...
The University of Illinois received a $284,659 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The purpose of the grant is to support research on the "Regeneration of the Bone Marrow Hematopoietic Niche by Jagged1-Expressing Myeloid-Derived Suppressor Cells." The award period runs from December 1, 2024 to November 30, 2026. The Military Medical Research and Development program funds advanced...
This Project Grant from the Defense Health Agency provides $8,351,133 to the Regents of the University of Michigan from May 1, 2023 to April 30, 2027. The grant supports research under the Military Medical Research and Development program (CFDA 12.420) to investigate the pivotal and diverse roles of matricellular proteins in musculoskeletal disorders. The University of Michigan will conduct the primary research. Two subawards totaling $XXX,XXX were also issued to support complementary work....
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $713,250 over 3 years to the Trustees of Indiana University (doing business as Indiana University) to conduct research targeting the CENPF-CENPE axis for the prevention and treatment of NF1-associated malignant peripheral nerve sheath tumors. The research aims to develop new approaches for addressing this condition, which impacts military service...